September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Genetic and environmental risk factors for extramacular drusen
Author Affiliations & Notes
  • Xavier Subiras Rodriguez
    Cologne Image Reading Center, Cologne, Germany
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Tina Schick
    Cologne Image Reading Center, Cologne, Germany
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Aileen Berghold
    Cologne Image Reading Center, Cologne, Germany
  • Bernd Kirchhof
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Anneke I den Hollander
    Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
  • Sascha Fauser
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Sandra Liakopoulos
    Cologne Image Reading Center, Cologne, Germany
    Department of Ophthalmology, University of Cologne, Cologne, Germany
  • Footnotes
    Commercial Relationships   Xavier Subiras Rodriguez, None; Tina Schick, None; Aileen Berghold, None; Bernd Kirchhof, None; Anneke I den Hollander, None; Sascha Fauser, None; Sandra Liakopoulos, None
  • Footnotes
    Support  Ilse Palm Foundation, Germany
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2630. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Xavier Subiras Rodriguez, Tina Schick, Aileen Berghold, Bernd Kirchhof, Anneke I den Hollander, Sascha Fauser, Sandra Liakopoulos; Genetic and environmental risk factors for extramacular drusen. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2630.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate genetic and environmental risk factors for extramacular drusen (EMD) in patients with and without age-related macular degeneration (AMD).

Methods : In this case-control study, 1148 individuals from a multicenter genetic database for AMD (EUGENDA) were included. Fundus photographs were analyzed for the presence of EMD (none; ≥10 EMD; ≥30 EMD). AMD staging was performed by trained graders. Evaluated risk factors included 41 non-genetic risk factors and 41 single nucleotide polymorphisms. Univariate regression analysis was performed after adjustment for AMD.

Results : At least 10 EMD were present in 500 subjects. Of these, 299 cases had ≥30 EMD. 587 individuals showed no AMD, 277 had early or intermediate AMD and 284 had late AMD. Genetic associations with EMD were found for the homozygous risk variant of ARMS2 (rs10490924) (Odds ratio (OR)=2.51; 95% Confidence Interval (CI)=1.45-4.36; p=0.001); the heterozygous risk variants of ADAMTS9 (rs6795735) (OR=1.54; CI=1.11-2.14; p=0.01) and VEGFA (rs943080) (OR=1.48; CI= 1.01-2.15; p=0.04). Associations were also found for past sunlight exposure (≥8h/day outside: OR= 6.83; CI=1.37-34.19; p=0.02) and current sunlight exposure (≥8h/day outside: OR= 7.28; CI=1.37-38.60; p=0.02; 4-8h/day outside: OR=5.55; CI=1.11-27.59; p=0.04). Analysis of subjects with ≥30 EMD showed significant associations with homozygous risk variants of ARMS2 (OR= 2.10; CI=1.12-3.98; p=0.02) and CFHY402H (rs1061170) (OR= 1.86; CI=1.13-3.06; p=0.01), past sunlight exposure (≥8 h/day outside: OR=15.37; CI= 1.50-157.54; p= 0.02) and current sunlight exposure (≥8h/day outside: OR= 16.90; CI=1.44-198.33; p=0.02; 4-8h/day outside: OR= 11.34; CI=1.04-124,04; p=0.047). Additionally, heterozygous risk variants of CFH (rs12144939) (OR= 0.61; CI=0.40-0.92; p=0.02) and SLC16A8 (rs8135665) (OR=0.66; CI=0.45-0.98; p=0.04) showed significant associations.

Conclusions : After adjustment for AMD, associations with ≥10 EMD were found for ARMS2 and sunlight exposure, however not for CFHY402H. At least 30 EMD were additionally associated with the homozygous but not with the heterozygous risk polymorphism in CFHY402H. CFH (rs12144939) and SLC16A8 appeared to have protective effects in EMD development. Additional AMD-independent factors may be involved in the pathogenesis of EMD and further studies are required to evaluate these risk factors.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×